Observational studyJournal of the neurological sciences2021

Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic.

Gerd Haga Bringeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.